The Preclinical Development of FTY720, A Sphingosine-1-Phosphate Receptor Modulator, as a Novel Targeting Therapy Against Breast Cancer
B.J. Adams, M. Nagahashi, S. Ramachandran, N.C. Hait, S. Milstien, S. Spiegel, K. TakabeVolume:
172
Year:
2012
Language:
english
DOI:
10.1016/j.jss.2011.11.349
File:
PDF, 41 KB
english, 2012